SynthesisFrontiers in pharmacology2026

Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.

Lichuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.